George JACKOWSKI

POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP

#2 | 2017-01-12

US20170010288A1

Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP

#3 | 2015-10-01

US20150272920A1

METHOD FOR TREATING OBESITY WITH ANTI-OBESITY FORMULATIONS AND OMEGA 3 FATTY ACIDS FOR THE REDUCTION OF BODY WEIGHT IN CARDIOVASCULAR DISEASE PATIENTS (CVD) AND DIABETICS

#4 | 2013-03-28

US20130079310A1

Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels

#5 | 2013-02-14

US20130040927A1

Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events

#6 | 2013-02-14

US20130040913A1

Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels

#7 | 2013-02-07

US20130034535A1

Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics

#8 | 2012-11-29

US20120302639A1

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

#9 | 2012-06-14

US20120149042A1

METHODS FOR PREDICTING OUTCOME IN TRAUMATIC BRAIN INJURY

#10 | 2012-05-03

US20120107848A1

Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP

#11 | 2011-07-28

US20110183436A1

Diagnostic methods for congestive heart failure

#12 | 2010-09-30

US20100248275A1

METHODS FOR PREDICTING OUTCOME IN TRAUMATIC BRAIN INJURY

#13 | 2010-08-03

US10359028

Calibrator for NT-proBNP immunoassay

#14 | 2010-06-03

US20100136593A1

Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

#15 | 2009-12-31

US20090325195A1

POLYCLONAL-MONOCLONAL ELISA ASSAY FOR DETECTING N-TERMINUS PRO-BNP

#16 | 2009-04-09

US20090093000A1

Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease

#17 | 2009-03-12

US20090068676A1

Diagnostic methods for congestive heart failure

#18 | 2008-04-24

US20080096286A1

Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons

#19 | 2008-01-01

US9845738

Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons

#20 | 2007-11-13

US9845715

Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons

#21 | 2007-08-16

US20070190666A1

Apolipoprotein biopolymer markers indicative of insulin resistance

#22 | 2007-08-09

US20070184507A1

Methods for predicting outcome in traumatic brain injury

#23 | 2007-02-08

US20070031979A1

Protein biopolymer markers predictive of type II diabetes

#24 | 2007-01-25

US20070020769A1

Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients

#25 | 2007-01-11

US20070010030A1

Complement C3 precursor biopolymer markers indicative of insulin resistance

#26 | 2007-01-11

US20070010029A1

Protein biopolymer markers predictive of insulin resistance

#27 | 2007-01-11

US20070009963A1

Apolipoprotein biopolymer marker indicative of normal human

#28 | 2007-01-04

US20070003974A1

Cene-E biopolymer marker indicative of age matched control

#29 | 2006-12-28

US20060292703A1

Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons

#30 | 2006-12-07

US20060275831A1

Complement C3 precursor biopolymer markers predictive of type II diabetes

#31 | 2006-11-14

US10359047

Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients

#32 | 2006-11-07

US9992067

Betaine/GABA transport protein biopolymer marker indicative of insulin resistance

#33 | 2006-09-21

US20060211150A1

Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance

#34 | 2006-09-21

US20060211149A1

Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance

#35 | 2006-09-21

US20060211148A1

Protein biopolymer markers indicative of age matched control

#36 | 2006-09-21

US20060211147A1

Protein biopolymer markers indicative of age matched control

#37 | 2006-09-21

US20060211146A1

Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance

#38 | 2006-09-21

US20060211145A1

Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance

#39 | 2006-09-21

US20060211144A1

Protein biopolymer markers indicative of age matched control

#40 | 2006-09-21

US20060211143A1

Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance

#41 | 2006-09-21

US20060211142A1

Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance

#42 | 2006-09-21

US20060211141A1

Protein biopolymer markers predictive of insulin resistance

#43 | 2006-09-21

US20060211140A1

Protein biopolymer markers predictive of insulin resistance

#44 | 2006-09-21

US20060211139A1

Protein biopolymer markers predictive of insulin resistance

#45 | 2006-09-21

US20060211138A1

Protein biopolymer markers predictive of insulin resistance

#46 | 2006-09-21

US20060211070A1

Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP

#47 | 2006-09-21

US20060211048A1

Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons

#48 | 2006-09-19

US10299583

Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients

#49 | 2006-09-14

US20060205091A1

Protein biopolymer markers predictive of insulin resistance

#50 | 2006-09-05

US9971740

Method for detecting the presence of monomeric brain associated human glutamine synthetase

#51 | 2006-08-31

US20060194340A1

Protein biopolymer markers predictive of type II diabetes

#52 | 2006-08-31

US20060194339A1

Protein biopolymer markers indicative of insulin resistance

#53 | 2006-08-31

US20060194338A1

Complement C3 precursor biopolymer markers indicative of insulin resistance

#54 | 2006-08-31

US20060194337A1

Fibronectin precursor biopolymer markers indicative of alzheimer's disease

#55 | 2006-08-08

US9846328

Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons

#56 | 2006-07-20

US20060160233A1

IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease

#57 | 2006-07-20

US20060160232A1

Complement C3 precursor biopolymer markers predictive of type II diabetes

#58 | 2006-07-13

US20060154321A1

Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP

#59 | 2006-07-11

US9992672

Protein biopolymer markers indicative of alzheimer's disease

#60 | 2006-07-04

US10246383

Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment

#61 | 2006-06-22

US20060134700A1

Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance

#62 | 2006-06-22

US20060134699A1

Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance

#63 | 2006-06-22

US20060134108A1

Method for retarding or precluding Alzheimer's dementia

#64 | 2006-05-30

US9991627

Protein biopolymer markers predictive of insulin resistance

#65 | 2006-05-23

US9845731

Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons

#66 | 2006-04-20

US20060084112A1

Biopolymer markers indicative of type II diabetes

#67 | 2006-04-11

US9991797

IG lambda biopolymer markers predictive of Alzheimers disease

#68 | 2006-03-30

US20060068505A1

Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons

#69 | 2006-03-21

US10334701

Method for retarding or precluding Alzheimer's dementia

#70 | 2006-03-09

US20060051877A1

Fibronectin biopolymer marker indicative of insulin resistance

#71 | 2006-03-09

US20060051814A1

Methods for predicting outcome in traumatic brain injury

#72 | 2006-03-07

US9846342

Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons

#73 | 2006-02-14

US9845739

Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

#74 | 2006-02-02

US20060024761A1

Protein biopolymer markers predictive of alzheimer's disease

#75 | 2006-02-02

US20060024755A1

Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons

#76 | 2006-02-02

US20060024671A1

Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons

#77 | 2005-12-29

US20050287613A1

Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP

#78 | 2005-12-29

US20050287599A1

Method and kit for diagnosing myocardial infarction

#79 | 2005-12-29

US20050287595A1

Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance

#80 | 2005-09-29

US20050214874A1

Diagnosis and treatment of early pre-Type-1 diabetes utilizing glial fibrillary acidic protein

#81 | 2005-06-23

US20050136496A1

Method for diagnosing and distinguishing stroke and diagnostic devices for use therein

#82 | 2005-06-16

US20050130245A1

Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins

#83 | 2005-05-12

US20050100964A1